Idaho Society of Cancer Oncology

Welcome

The Idaho Society of Clinical Oncology (ISCO) represents Idaho physicians and related health care professionals who care for cancer patients. The Society is a non-profit corporation devoted to the improvement of hematologic and oncologic care of patients.

The Benefits of Membership

Membership in the Society is open to all professionals whose primary endeavor is the delivery of oncology care,  including physicians, nurse practitioners, physician assistants and pharmacists. Membership is restricted to those individuals primarily delivering care in the State of Idaho and is FREE to qualified professionals

 

Join Today

 

Upcoming Events

ISCO Spring Corporate Meeting
May 10, 2019
Saint Alphonsus Regional Medical Center

ISCO Fall Meeting
November 1-2, 2019
The Grove Hotel | Boise


 

CMS Releases Physician Fee Schedule Final Rule
The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Physician Fee Schedule (PFS) rule. The agency responded to the overwhelming negative stakeholder response to its proposal to revise evaluation and management (E/M) documentation requirements and payment by significantly revising its final policy.

Click here for more.

CMS Releases Final Hospital Outpatient Payment Rule - The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Hospital Outpatient Prospective Payment System (OPPS) rule. In the Society’s comment letter, ASH requested that CMS change the status indicator for the four new Category III CPT codes for chimeric antigen receptor (CAR) T-cell therapy from “B” to “S.” In the final rule, CMS did finalize this change for one of the four codes, code 0540T, CAR-T cell administration, autologous. 

Click here for the report.